Peptinovo Biopharma
Dr. Bill Elliott, PhD (Co-founder) has broad experience in cancer drug discovery and development from his work at Parke-Davis, Molecular Imaging Research, and Karmanos Cancer Institute. Bill cofounded Molecular Imaging Research, which Charles River Laboratories subsequently acquired. Bill serves as Chief Technology Officer.
Peptinovo Biopharma
1 followers
Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.